Harrow Health

About

Harrow Health is an eye health pharmaceutical company.

Nashville,Tennessee,United States
101 - 250
https://www.harrowinc.com/

Highlights

Details

Last Funding Type: Post-IPO Equity
Last Funding Money Raised: $25M
Industries: Biotechnology,Health Care,Medical
Founded date: Jan 1, 1998
Number Of Employee: 101 - 250
Operating Status: Active
Stock Symbol: nasdaq:HROW
Legal Name: Harrow Health, Inc.
Also Known As: Imprimis Pharmaceuticals, Inc.,TRANSDEL PHARMACEUTICALS INC,Bywater Resources, Inc

Harrow Health, Inc. (Nasdaq: HROW) is an eye health pharmaceutical company focused on the development, production, sale, and distribution of innovative ophthalmic prescription medications that are accessible and affordable. For more information about Harrow Health, please visit the Investors section of the corporate website,www.harrowinc.com.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

7

$123.74M

Harrow Health has raised a total of $123.74M in funding over 2 rounds. Their latest funding was raised on Dec 14, 2022 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 14, 2022	Post-IPO Equity	$25M	—	—	—	Detail
Apr 14, 2021	Post-IPO Debt	$50M	—	—	—	Detail
Jul 20, 2017	Post-IPO Debt	$16M	1	SWK Funding	—	Detail
Dec 19, 2016	Post-IPO Equity	$9.80M	—	—	—	Detail
May 12, 2015	Post-IPO Debt	$15M	1	—	—	Detail